IMNM - SEC Form 4 insider transactions

SEC Form 4 filed by Higgins Jack

SEC Form 4 filed by Rosett Max

SEC Form 4 filed by Higgins Jack

SEC Form 4 filed by Siegall Clay B

SEC Form 4 filed by Wagenheim Philip

Director Barchas Isaac sold $8,330,080 worth of shares (383,200 units at $21.74) (SEC Form 4)

Chief Scientific Officer Higgins Jack gifted 3,000 shares and received a gift of 3,000 shares, decreasing direct ownership by 7% to 37,729 units (SEC Form 4)

Chief Scientific Officer Higgins Jack exercised 22,000 shares at a strike of $1.35, increasing direct ownership by 117% to 40,729 units (SEC Form 4)

SEC Form 4 filed by Chief Technical Officer Tsai Philip

SEC Form 4 filed by Chief Financial Officer Rosett Max

SEC Form 4 filed by Chief Medical Officer Lechleider Robert

SEC Form 4 filed by CHIEF BUSINESS OFFICER Horn Kinney

SEC Form 4 filed by Chief Scientific Officer Higgins Jack

SEC Form 4 filed by President and CEO Siegall Clay B

SEC Form 4 filed by CHIEF LEGAL OFFICER & GC Stoneman Sandra G.

SEC Form 4 filed by Director Boylan James P

SEC Form 4 filed by Director Schafer Carol

SEC Form 4 filed by Director Wagenheim Philip

SEC Form 4 filed by Director Barchas Isaac

SEC Form 4 filed by Director Bienaime Jean Jacques

SEC Form 4 filed by Director Swain Sandra M

Chief Scientific Officer Higgins Jack exercised 5,200 shares at a strike of $1.35, increasing direct ownership by 38% to 18,729 units (SEC Form 4)

Chief Financial Officer Rosett Max exercised 42,000 shares at a strike of $1.05 and sold $230,224 worth of shares (14,380 units at $16.01), increasing direct ownership by 139% to 47,476 units (SEC Form 4)

Chief Scientific Officer Higgins Jack gifted 2,471 shares, exercised 19,524 shares at a strike of $1.35 and sold $49,072 worth of shares (3,524 units at $13.93) (SEC Form 4)

SEC Form 4 filed by President and CEO Siegall Clay B

SEC Form 4 filed by CHIEF LEGAL OFFICER & GC Stoneman Sandra G.

SEC Form 4 filed by CHIEF BUSINESS OFFICER Horn Kinney

SEC Form 4 filed by Chief Strategy Officer Turner Bruce

SEC Form 4 filed by EVP, Operations & CFO Rosett Max

SEC Form 4 filed by Chief Medical Officer Lechleider Robert

SEC Form 4 filed by Chief Scientific Officer Higgins Jack

SEC Form 4 filed by Chief Technology Officer Tsai Philip

SEC Form 4 filed by Director Boylan James P

SEC Form 4 filed by Director Schafer Carol

SEC Form 4 filed by Director Swain Sandra M

SEC Form 4 filed by Director Wagenheim Philip

SEC Form 4 filed by Director Bienaime Jean Jacques

SEC Form 4 filed by Director Barchas Isaac

SEC Form 4 filed by Rosett Max

SEC Form 4 filed by Swain Sandra M

SEC Form 4 filed by Horn Kinney

SEC Form 4 filed by Rosett Max

SEC Form 4 filed by Stoneman Sandra G.

SEC Form 4 filed by Schafer Carol

SEC Form 4 filed by Roberts Phil Noland

SEC Form 4 filed by Higgins Jack

SEC Form 4 filed by Bienaime Jean Jacques

SEC Form 4 filed by Barchas Isaac

SEC Form 4 filed by Boylan James P

SEC Form 4 filed by Lechleider Robert

Prendergast Franklyn G was granted 60,840 shares (SEC Form 4)

Rapp Michael was granted 253,806 shares, increasing direct ownership by 31% to 1,071,172 units (SEC Form 4)

SEC Form 4 filed by Rapp Michael

SEC Form 4 filed by Stoneman Sandra G.

SEC Form 4 filed by Roche Corleen M.

SEC Form 4 filed by Robinson Matthew K

SEC Form 4 filed by Sarma Purnanand D

SEC Form 4 filed by Lefenfeld Michael

SEC Form 4 filed by Lamattina John L

SEC Form 4 filed by Baron Richard A